India's largest platform and marketplace for GCCs & AI

Sign in

India's largest platform and marketplace for GCCs & AI

3AI Digital Library

Pandemic has “fundamentally accelerated” the process of digital transformation – Satya Nadella

3AI February 1, 2021

“What we were going to think about during 2030 is probably going to be true in 2025,” Nadella added. He was speaking at the Resurgence TiEcon Delhi-NCR summit.

Picture from freepik.com

    3AI Trending Articles

  • AI will drive next wave of Digital Transformation: A perspective

    In the past months, most of you may have run into a situation where you open the GPS app on your smartphone and it ‘knows’ where you would like to go because it fits a certain repetitive pattern of behaviour or the photo app organizing your pictures based on who are the most important people […]

  • View: The way countries handle Foreign Policy will change due to Digital Transformation

    The way countries handle foreign policy will change irreversibly in the future due to digital transformation. . There is hardly any aspect of life that hasn’t been affected by the Covid-19 pandemic. New technologies, inventions and well-organised tools are being developed every day. Digital transformation has occurred all around us. It impacted every business, reducing […]

  • Evolution of Biometric Recognition Systems with AI

    Featured Article: Author: Kiranjit Pattnaik, MiQ What are biometric recognition systems Biometric recognition systems are computer-based systems that use an individual’s physical characteristics, such as their fingerprint, voice, face or any other part of the body, to authenticate their identity and grant access to secure areas, systems, or services. They are used increasingly as an […]

  • AI in Drug Discovery

    Featured Article: Author: Vijay Morampudi, Director & Head of AI, Wavelabs Technologies Drug discovery takes 12-15 years and a median investment of nearly $1 billion to bring a new drug to market. While the true cost of research and development may be as high as $2.5 billion per marketed therapy, when factoring in abandoned trials and […]